Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of TAS-102 and irinotecan in metastatic colorectal cancer
jRCT2080222053Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trifluridine + tipiracil and irinotecan in colorectal cancer (CRC), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
trifluridine + tipiracilirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080222053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222053.